ahlam1399
09-16-2016, 01:32 AM
BRIEF-Amgen presents positive data at EHMTIC 2016, Erenumab reduces mi*****e
* Amgen presents positive data at EHMTIC 2016 demonstratingerenumab significantly reduces monthly mi*****e days in patientswith chronic mi*****ehttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=XFgWOHS0uhQ:Fu18vyBaGmc:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=XFgWOHS0uhQ:Fu18vyBaGmc:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=XFgWOHS0uhQ:Fu18vyBaGmc:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=XFgWOHS0uhQ:Fu18vyBaGmc:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=XFgWOHS0uhQ:Fu18vyBaGmc:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/XFgWOHS0uhQ
* Amgen presents positive data at EHMTIC 2016 demonstratingerenumab significantly reduces monthly mi*****e days in patientswith chronic mi*****ehttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=XFgWOHS0uhQ:Fu18vyBaGmc:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=XFgWOHS0uhQ:Fu18vyBaGmc:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=XFgWOHS0uhQ:Fu18vyBaGmc:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=XFgWOHS0uhQ:Fu18vyBaGmc:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=XFgWOHS0uhQ:Fu18vyBaGmc:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/XFgWOHS0uhQ